CP47,497-C8 and JWH073, commonly found in 'Spice' herbal blends, are potent and efficacious CB1 cannabinoid receptor agonists

European Journal of Pharmacology

Volumn 659, Issue 2-3, 2011, Pages 139-145

  Atwood, Brady K ^a,b   Lee, Donghoon ^a   Straiker, Alex ^a   Widlanski, Theodore S ^a   Mackie, Ken ^a  

^a INDIANA UNIVERSITY   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Cannabinoid; CB1 receptor; CP47,497 C8; JWH018; JWH073; Spice

Indexed keywords

CANNABINOID 1 RECEPTOR; CANNABINOID 1 RECEPTOR AGONIST; CP 47 797C 8; JWH 073; RIMONABANT; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL STRAIN; CELLULAR DISTRIBUTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFICACY; DRUG POTENCY; DRUG RECEPTOR BINDING; DRUG STRUCTURE; DRUG SYNTHESIS; DRUG TARGETING; HIPPOCAMPUS; INTERNALIZATION; MOUSE; NERVE CELL CULTURE; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SPICE;

ANIMALS; CELL LINE; CYCLOHEXANOLS; INDOLES; MICE; NAPHTHALENES; PLANT EXTRACTS; PROTEIN TRANSPORT; RECEPTOR, CANNABINOID, CB1; STEREOISOMERISM; STRUCTURE-ACTIVITY RELATIONSHIP; SUBSTANCE-RELATED DISORDERS; SYNAPTIC TRANSMISSION;

EID: 79955928510     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2011.01.066     Document Type: Article

References (40)

1. Ameri, A., Wilhelm, A., Simmet, T., 1999. Effects of the endogeneous cannabinoid, anandamide, on neuronal activity in rat hippocampal slices. Br. J. Pharmacol. 126, 1831-1839.
2. Atwood, B.K., Huffman, J., Straiker, A., Mackie, K., 2010. JWH018, a common constituent of 'Spice' herbal blends, is a potent and efficacious cannabinoid CB(1) receptor agonist. Br. J. Pharmacol. 160, 585-593.
3. Aung, M.M., Griffin, G., Huffman, J.W.,Wu, M., Keel, C., Yang, B., Showalter, V.M., Abood,M. E.,Martin, B.R., 2000. Influence of the N-1 alkyl chain length of cannabimimetic indoles upon CB(1) and CB(2) receptor binding. Drug Alcohol Depend. 60, 133-140.
4. Auwarter, V., Dresen, S., Weinmann, W., Muller, M., Putz, M., Ferreiros, N., 2009. 'Spice' and other herbal blends: harmless incense or cannabinoid designer drugs? J. Mass Spectrom. 44, 832-837.
5. Bekkers, J.M., Stevens, C.F., 1991. Excitatory and inhibitory autaptic currents in isolated hippocampal neurons maintained in cell culture. Proc. Natl Acad. Sci. USA 88, 7834-7838.
6. Brown, S.M., Wager-Miller, J., Mackie, K., 2002. Cloning and molecular characterization of the rat CB2 cannabinoid receptor. Biochim. Biophys. Acta 1576, 255-264.
7. Chevaleyre, V., Takahashi, K.A., Castillo, P.E., 2006. Endocannabinoid-mediated synaptic plasticity in the CNS. Annu. Rev. Neurosci. 29, 37-76.
8. Compton, D.R., Johnson, M.R., Melvin, L.S., Martin, B.R., 1992. Pharmacological profile of a series of bicyclic cannabinoid analogs: classification as cannabimimetic agents. J. Pharmacol. Exp. Ther. 260, 201-209.
9. Costa, B., 2007. On the pharmacological properties of delta9-tetrahydrocannabinol (THC). Chem. Biodivers. 4, 1664-1677.
10. Daigle, T.L., Kearn, C.S., Mackie, K., 2008. Rapid CB1 cannabinoid receptor desensitization defines the time course of ERK1/2 MAP kinase signaling. Neuropharmacology 54, 36-44. (Pubitemid 350299401)
11. Furshpan, E.J., MacLeish, P.R., O'Lague, P.H., Potter, D.D., 1976. Chemical transmission between rat sympathetic neurons and cardiac myocytes developing in microcultures: evidence for cholinergic, adrenergic, and dual-function neurons. Proc. Natl Acad. Sci. USA 73, 4225-4229.
12. Griffin, G., Atkinson, P.J., Showalter, V.M., Martin, B.R., Abood, M.E., 1998. Evaluation of cannabinoid receptor agonists and antagonists using the guanosine-5′-O-(3-[35S] thio)-triphosphate binding assay in rat cerebellar membranes. J. Pharmacol. Exp. Ther. 285, 553-560.
13. Griffiths, P., Sedefov, R., Gallegos, A., Lopez, D., 2010. How globalization and market innovation challenge how we think about and respond to drug use: 'Spice' a case study. Addiction 105, 951-953.
14. Hammersley, R., 2010. Dangers of banning spice and the synthetic cannabinoid agonists. Addiction 105, 373.
15. Howlett, A.C., 2002. The cannabinoid receptors. Prostaglandins Other Lipid Mediat. 68-69, 619-631. (Pubitemid 35247425)
16. Howlett, A.C., Barth, F., Bonner, T.I., Cabral, G., Casellas, P., Devane, W.A., Felder, C.C., Herkenham, M., Mackie, K., Martin, B.R., Mechoulam, R., Pertwee, R.G., 2002. International union of pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol. Rev. 54, 161-202.
17. Hsieh, C., Brown, S., Derleth, C., Mackie, K., 1999. Internalization and recycling of the CB1 cannabinoid receptor. J. Neurochem. 73, 493-501. (Pubitemid 29339821)
18. Hudson, S., Ramsey, J., King, L., Timbers, S., Maynard, S., Dargan, P.I., Wood, D.M., 2010. Use of high-resolution accurate mass spectrometry to detect reported and previously unreported cannabinomimetics in "herbal high" products. J. Anal. Toxicol. 34, 252-260.
19. Huestis, M.A., Gorelick, D.A., Heishman, S.J., Preston, K.L., Nelson, R.A., Moolchan, E.T., Frank, R.A., 2001. Blockade of effects of smoked marijuana by the CB1-selective cannabinoid receptor antagonist SR141716. Arch. Gen. Psychiatry 58, 322-328.
20. Huffman, J.W., Dong, D., Martin, B.R., Compton, D.R., 1994. Design, synthesis and pharmacology of cannabimimetic indoles. Bioorg. Med. Chem. Lett. 4, 563-566.
21. Jin, W., Brown, S., Roche, J.P., Hsieh, C., Celver, J.P., Kovoor, A., Chavkin, C., Mackie, K., 1999. Distinct domains of the CB1 cannabinoid receptor mediate desensitization and internalization. J. Neurosci. 19, 3773-3780. (Pubitemid 29222253)
22. Katona, I., Urban, G.M., Wallace, M., Ledent, C., Jung, K.M., Piomelli, D., Mackie, K., Freund, T.F., 2006. Molecular composition of the endocannabinoid system at glutamatergic synapses. J. Neurosci. 26, 5628-5637. (Pubitemid 44315254)
23. Koch, T., Höllt, V., 2008. Role of receptor internalization in opioid tolerance and dependence. Pharmacol. Ther. 117, 199-206.
24. Koch, T., Widera, A., Bartzsch, K., Schulz, S., Brandenburg, L.O., Wundrack, N., Beyer, A., Grecksch, G., Höllt, V., 2005. Receptor endocytosis counteracts the development of opioid tolerance. Mol. Pharmacol. 67, 280-287.
25. Lindigkeit, R., Boehme, A., Eiserloh, I., Luebbecke, M., Wiggermann, M., Ernst, L., Beuerle, T., 2009. Spice: a never ending story? Forensic Sci. Int. 191, 58-63.
26. Mackie, K., 2005. Distribution of cannabinoid receptors in the central and peripheral nervous system. Handb. Exp. Pharmacol. 299-325.
27. McLachlan, G., 2009. Taking the spice out of legal smoking mixtures. Lancet 374, 600.
28. Melvin, L.S., Johnson, M.R., Harbert, C.A., Milne, G.M., Weissman, A., 1984. A cannabinoid derived prototypical analgesic. J. Med. Chem. 27, 67-71.
29. Melvin, L.S., Milne, G.M., Johnson, M.R., Subramaniam, B., Wilken, G.H., Howlett, A.C., 1993. Structure-activity relationships for cannabinoid receptor-binding and analgesic activity: studies of bicyclic cannabinoid analogs. Mol. Pharmacol. 44, 1008-1015.
30. Monory, K., Blaudzun, H., Massa, F., Kaiser, N., Lemberger, T., Schutz, G., Wotjak, C.T., Lutz, B., Marsicano, G., 2007. Genetic dissection of behavioural and autonomic effects of delta(9)-tetrahydrocannabinol in mice. PLoS Biol. 5, e269.
31. Muller, H., Sperling, W., Kohrmann, M., Huttner, H.B., Kornhuber, J., Maler, J.M., 2010. The synthetic cannabinoid Spice as a trigger for an acute exacerbation of cannabis induced recurrent psychotic episodes. Schizophr. Res. 118, 309-310.
32. Pertwee, R.G., 2008. The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin. Br. J. Pharmacol. 153, 199-215.
33. Roche, J.P., Bounds, S., Brown, S., Mackie, K., 1999. A mutation in the second transmembrane region of the CB1 receptor selectively disrupts G protein signaling and prevents receptor internalization. Mol. Pharmacol. 56, 611-618.
34. Shen, M., Piser, T.M., Seybold, V.S., Thayer, S.A., 1996. Cannabinoid receptor agonists inhibit glutamatergic synaptic transmission in rat hippocampal cultures. J. Neurosci. 16, 4322-4334. (Pubitemid 26243028)
35. Straiker, A., Mackie, K., 2005. Depolarization-induced suppression of excitation in murine autaptic hippocampal neurones. J. Physiol. 569, 501-517. (Pubitemid 41830118)
36. Uchiyama, N., Kikura-Hanajiri, R., Ogata, J., Goda, Y., 2010. Chemical analysis of synthetic cannabinoids as designer drugs in herbal products. Forensic Sci. Int. 198, 31-38.
37. Vardakou, I., Pistos, C., Spiliopoulou, C., 2010. Spice drugs as a new trend: mode of action, identification and legislation. Toxicol. Lett. 197, 157-162.
38. Wiley, J.L., Compton, D.R., Dai, D., Lainton, J.A., Phillips, M., Huffman, J.W., Martin, B.R., 1998. Structure-activity relationships of indole- and pyrrole-derived cannabinoids. J. Pharmacol. Exp. Ther. 285, 995-1004.
39. Wu, D.F., Yang, L.Q., Goschke, A., Stumm, R., Brandenburg, L.O., Liang, Y.J., Höllt, V., Koch, T., 2008. Role of receptor internalization in the agonist-induced desensitization of cannabinoid type 1 receptors. J. Neurochem. 104, 1132-1143. (Pubitemid 351143650)
40. Zimmermann, U.S., Winkelmann, P.R., Pilhatsch, M., Nees, J.A., Spanagel, R., Schulz, K., 2009. Withdrawal phenomena and dependence syndrome after the consumption of "spice gold". Dtsch. Arztebl. Int. 106, 464-467.